ArticleBMC gastroenterology2017

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.

Lorant Gonczi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.